Biocorp (PAR:ALCOR) said today that its smart cap, Easylog, won CE Mark clearance for use with insulin delivery devices.
The company’s device turns traditional pen injectors into connected devices, capturing treatment information like dose, date and time of injection. Easylog transfers that data to a mobile app for patients to monitor.
Get the full story at our sister site, Drug Delivery Business News.
The post BioCorp’s smart cap wins CE Mark for insulin pen appeared first on MassDevice.
from MassDevice http://ift.tt/2oXqJmM
Cap comentari:
Publica un comentari a l'entrada